In 2017, in the study of Mayo Clinic et al. (14), about 25% of patients with anti-LGI1 and CASPR2 antibodies had autonomic symptoms of which orthostatic hypotension and reduced sweating were the most common symptoms. Here, LGI1 is linked to hypotensive disorder.